Procainamide Hydrochloride Injection, Solution
Product Images NDC 25021-322

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Procainamide Hydrochloride (NDC 25021-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pro2i 0000 01)

This is a chemical formula involving NH2 and CONHCH2CH2N(C2Hs)2 = HCI with a molecular weight of 271.79. It may represent a specific compound or reaction which requires further analysis to determine its exact nature and properties.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pro2i 0000 02)

The text provides information about the medication Procrinamide Hydrochloride Injection, which is presented in a 1 gram per 10 mL solution for Intramuscular or Intravenous use after dilution. The medication is contained in a 10 mL multi-dose vial and is to be used for pH adjustment. It is important to note that the medication contains metabisulfites and may also contain preservatives such as methylparaben. This sterile, nonpyrogenic medication is manufactured by Sagent Pharmaceuticals in India.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pro2i 0000 03)

This text provides information about a medication called Procainamide 2% Hydrochloride Injection, USP, which is contained in a 2 mL multi-dose vial. It warns that the medication contains Metabisulfites. The text also mentions specific product details like the NDC number and manufacturing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.